Cargando…
Leukemia and rosiglitazone
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792895/ https://www.ncbi.nlm.nih.gov/pubmed/27013916 http://dx.doi.org/10.1016/j.jsps.2015.03.017 |
| _version_ | 1782421301901656064 |
|---|---|
| author | Yavasoglu, Irfan Kadikoylu, Gurhan Bolaman, Zahit |
| author_facet | Yavasoglu, Irfan Kadikoylu, Gurhan Bolaman, Zahit |
| author_sort | Yavasoglu, Irfan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4792895 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47928952016-03-24 Leukemia and rosiglitazone Yavasoglu, Irfan Kadikoylu, Gurhan Bolaman, Zahit Saudi Pharm J Letter to the Editor Elsevier 2016-03 2015-04-25 /pmc/articles/PMC4792895/ /pubmed/27013916 http://dx.doi.org/10.1016/j.jsps.2015.03.017 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Yavasoglu, Irfan Kadikoylu, Gurhan Bolaman, Zahit Leukemia and rosiglitazone |
| title | Leukemia and rosiglitazone |
| title_full | Leukemia and rosiglitazone |
| title_fullStr | Leukemia and rosiglitazone |
| title_full_unstemmed | Leukemia and rosiglitazone |
| title_short | Leukemia and rosiglitazone |
| title_sort | leukemia and rosiglitazone |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792895/ https://www.ncbi.nlm.nih.gov/pubmed/27013916 http://dx.doi.org/10.1016/j.jsps.2015.03.017 |
| work_keys_str_mv | AT yavasogluirfan leukemiaandrosiglitazone AT kadikoylugurhan leukemiaandrosiglitazone AT bolamanzahit leukemiaandrosiglitazone |